ELECTRIC SCRIBE 2000 LIMITED

Financial Health Assessment: Electric Scribe 2000 Limited

1. Financial Health Score: D-

Explanation: The patient is in critical condition and suffering from severe financial insolvency. The company’s liabilities vastly exceed its assets, and it possesses virtually no liquidity to cover its immediate debts. The only reason this score is not an outright 'F' is because the company is currently on financial "life support"—explicitly relying on the director's willingness to fund operations and forego calling in debts. Without this external intervention, the company would face immediate administration.

2. Key Vital Signs

Interpreting the numbers requires looking at the company's vital signs, which currently show a patient in acute distress:

• Blood Pressure (Liquidity): Critically Low. The company has only £1,361 in cash to satisfy £47,462 in current liabilities. This gives a current ratio of roughly 0.03. In medical terms, the company's financial blood pressure is far too low to sustain healthy operations; it cannot possibly pay its bills as they fall due from its own resources.
• Weight (Net Assets): Emaciated/Negative. Net assets stand at a negative £-33,353. The company is technically "underwater"—owing over £2.70 for every £1 of asset it owns. This has worsened significantly from the prior year (-£14,643).
• Heartbeat (Cash Trend): Weakening. Cash reserves have deteriorated steadily from £16,122 in 2020 to just £1,361 in 2024. The patient is bleeding out financially.
• Cholesterol (Liabilities): Dangerously High. Liabilities have surged by £11,353 in a single year. The primary blockages are "Taxation and social security" (£22,315) and "Other creditors" (£25,148), which likely includes director loans and accrued costs.

3. Diagnosis

Condition: Chronic Insolvency Dependent on Life Support

The financial data reveals a business that is fundamentally insolvent from a balance sheet perspective. However, the notes to the accounts provide the crucial diagnosis: the company is prepared on a "going concern basis because of the continuing financial support provided by the director."

In medical terms, the director is acting as the ventilator keeping this patient breathing. The accumulation of "Other creditors" strongly suggests the director is loaning money to the business or allowing unpaid expenses to accrue, rather than injecting equity (share capital remains a mere £100).

The business, which operates in niche sectors (non-scheduled air transport, IT, and R&D), appears to be either minimally trading or functioning as a vehicle for specific projects. With only one employee (the director), the high fixed asset base (£2,901) and investments (£9,847) suggest historical activity, but the current vital signs indicate the business is not generating enough organic revenue to sustain itself.

4. Recommendations

To stabilize the patient and prevent terminal decline, the following interventions are required:

1. Blood Transfusion (Formalize Capital): The director must convert the accumulated "Other creditor" loans into formal equity. This won't instantly cure the negative net assets, but it will restructure the debt, removing the immediate threat of the director calling in the loans and forcing liquidation.
2. Arterial Clearout (Liability Management): The tax liability of over £22k is a statutory priority that cannot be ignored. A structured payment plan (Time to Pay) should be negotiated with HMRC before enforcement action is taken, which could prove fatal to the business.
3. Pacemaker (Revenue Generation): The steady decline in cash reserves must be arrested. If the company cannot generate sufficient turnover to cover its operating costs and tax liabilities, the director must seriously consider whether keeping the entity alive is viable or if it is time to cease trading.
4. Health Review (Asset Realization): The company holds £9,847 in investments. If these are liquid, they should be evaluated for sale to provide a vital cash injection to pay down the most pressing creditors.